19 May 2013
Keywords: roche, mircera, gets, eu, approval, ckd-related, anemia
Article | 30 July 2007
Swiss drug major Roche says that the European Commission has approved Mircera, its continuous erythropoietin receptor activator, as a
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 July 2007
17 May 2013
© 2013 thepharmaletter.com